fda drug safety communication naion semaglutide 2025 GLP-1 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom Safe use of compounded GLP

However, not all weight loss plateaus on semaglutide are a result of the drug losing potency, even if you arent at the maximum dose

Ozempic joint or muscle pain may be due to underlying health conditions, other medications, injection site pain, dehydration, or increased exercise

Still, FDA approval of the Wegovy pill could prove financially favorable for Novo Nordisk, which has faced numerous challenges in 2025, including disappointing results from its clinical trial of semaglutide as a treatment for Alzheimers.

[18] [19] Remember that semaglutide is a long-term therapy

This page describes a prescription product manufactured by Novo Nordisk A/S